These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Differential effects of sugars and the alpha-glucosidase inhibitor acarbose (Bay g 5421) on satiety in the Zucker obese rat. Maggio CA, Decarr LB, Vasselli JR. Int J Obes; 1987; 11 Suppl 3():53-6. PubMed ID: 3326848 [Abstract] [Full Text] [Related]
27. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man. Hillebrand I, Boehme K, Frank G, Fink H, Berchtold P. Res Exp Med (Berl); 1979 Apr 23; 175(1):81-6. PubMed ID: 375342 [Abstract] [Full Text] [Related]
28. Inhibition of carbohydrate-induced hypertriglyceridemia by a disaccharidase inhibitor. Zavaroni I, Reaven GM. Metabolism; 1981 Apr 23; 30(4):417-20. PubMed ID: 7010078 [Abstract] [Full Text] [Related]
29. Effect of sucrose and Acarbose feeding on the development of streptozotocin-induced diabetes in the rat. Goda T, Yamada K, Sugiyama M, Moriuchi S, Hosoya N. J Nutr Sci Vitaminol (Tokyo); 1982 Feb 23; 28(1):41-56. PubMed ID: 6212654 [Abstract] [Full Text] [Related]
34. The effect of alpha-glucosidase inhibition on intestinal disaccharidase activity in normal and diabetic mice. Lee SM, Bustamante SA, Koldovský O. Metabolism; 1983 Aug 23; 32(8):793-9. PubMed ID: 6346004 [No Abstract] [Full Text] [Related]
35. The effect of acarbose and miglitol (BAY-M-1099) on postprandial glucose levels following ingestion of various sources of starch by nondiabetic and streptozotocin-induced diabetic rats. Madar Z. J Nutr; 1989 Dec 23; 119(12):2023-9. PubMed ID: 2695605 [Abstract] [Full Text] [Related]
37. Acarbose and 1-deoxynojirimycin inhibit maltose and maltooligosaccharide hydrolysis of human small intestinal glucoamylase-maltase in two different substrate-induced modes. Breitmeier D, Günther S, Heymann H. Arch Biochem Biophys; 1997 Oct 01; 346(1):7-14. PubMed ID: 9328278 [Abstract] [Full Text] [Related]
38. Effects of a glucosidase inhibitor (acarbose, BAY g 5421) on the development of obesity and food motivated behavior in Zucker (fafa) rats. Vasselli JR, Haraczkiewicz E, Maggio CA, Greenwood MR. Pharmacol Biochem Behav; 1983 Jul 01; 19(1):85-95. PubMed ID: 6622510 [Abstract] [Full Text] [Related]
39. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: dose-time-response relationships in man. Hillebrand I, Boehme K, Frank G, Fink H, Berchtold P. Res Exp Med (Berl); 1979 Apr 23; 175(1):87-94. PubMed ID: 375343 [Abstract] [Full Text] [Related]
40. Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose). Qualmann C, Nauck MA, Holst JJ, Orskov C, Creutzfeldt W. Scand J Gastroenterol; 1995 Sep 23; 30(9):892-6. PubMed ID: 8578189 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]